Literature DB >> 8338998

Pulmonary vascular resistance in complete atrioventricular septal defect. A comparison between children with and without Down's syndrome.

J Hals1, P S Hagemo, E Thaulow, S J Sørland.   

Abstract

Invasive data obtained in children with complete atrioventricular septal defect over the last three years are presented to determine the age at which pulmonary vascular obstructive disease develops. Comparisons were made between children with (n = 21) and without Down's syndrome (n = 12). The investigation was restricted to patients less than one year of age at initial catheterization. Patients with complicated associated heart defects were excluded. Patients with Down's syndrome had a higher ratio of pulmonary to systemic vascular resistance than children without Down's syndrome in the basal situation. This difference almost disappeared after 100% oxygen had been given to patients with elevated pulmonary vascular resistance, indicating that hypoxia and/or hypoventilation is of importance, especially in children with Down's syndrome. Fixed elevated pulmonary vascular resistance was found in 11% of Down patients under one year, with the youngest patient being 5.5 months old. One child without Down's syndrome may have had fixed elevated pulmonary vascular resistance. It is concluded that all children with complete atrioventricular septal defect should be evaluated and operated on at a very young age.

Entities:  

Mesh:

Year:  1993        PMID: 8338998     DOI: 10.1111/j.1651-2227.1993.tb12763.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  3 in total

1.  Management of Congenital Heart Disease: State of the Art; Part I-ACYANOTIC Heart Defects.

Authors:  P Syamasundar Rao
Journal:  Children (Basel)       Date:  2019-03-08

2.  Effect of bosentan on exercise capacity and clinical worsening in patients with dual down and eisenmenger syndrome.

Authors:  Giorgio Serino; Marco Guazzi; Angelo Micheletti; Carlo Lombardi; Rossella Danesi; Diana Negura; Mario Carminati; Massimo Chessa
Journal:  Clin Med Insights Cardiol       Date:  2013-02-06

Review 3.  Recent advances in managing septal defects: ventricular septal defects and atrioventricular septal defects.

Authors:  P Syamasundar Rao; Andrea D Harris
Journal:  F1000Res       Date:  2018-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.